Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
07/2010
07/15/2010DE102009004197A1 Heterocyclisch anellierte Diaryldihydropyrimidin-Derivate und ihre Verwendung Fused heterocyclic derivatives and their use Diaryldihydropyrimidin
07/15/2010CA2748181A1 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
07/15/2010CA2747161A1 Compounds and methods of use
07/14/2010EP2206749A1 Phthalocyanine compound
07/14/2010EP2206715A1 Fused heterotetracyclic compounds and use thereof as hcv polymerase inhibitor
07/14/2010EP2206714A1 Agent for prevention and/or treatment of skin diseases
07/14/2010EP2205604A1 {[5-(phenyl)-6-phenylpyrrolo[2,1-f][2,1,4]triazin-4-yl]amino}carboxylic acid derivatives and related compounds as prostacyclin (pgi2) ip receptor activators for treating cardiovascular disorders
07/14/2010EP2205603A1 Pyrimidine derivatives as protein kinase inhibitors
07/14/2010EP2205241A1 Polo-like kinase inhibitors
07/14/2010EP1991223B1 Novel imidazolopyrazole derivatives useful as selective androgen receptor modulators
07/14/2010EP1863812B1 Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
07/14/2010EP1784188B1 Fused triazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
07/14/2010EP1751161B1 Diazaindole-dicarbonyl-piperazinyl antiviral agents
07/14/2010EP1575959B1 Compositions useful as inhibitors of protein kinases
07/14/2010CN1980933B Amide derivatives of 3-phenyl dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents
07/14/2010CN101778851A Fused bicyclic pyrimidines
07/14/2010CN101778850A heteroaryl amide analogues
07/14/2010CN101775019A Melotenine and pharmaceutical composition as well as preparation method and application thereof
07/14/2010CN101775018A Substituted 1H pyrazolo [3,4-d] pyrimidin-4(5H)-ketone derivatives with weeding activity and preparation thereof
07/14/2010CN101775017A macrocyclic hepatitis c serine protease inhibitors
07/13/2010USRE41439 Pharmaceutical compositions and methods for use
07/13/2010US7755826 extends excitation wavelength for the photocyclization of the diarylethene moiety from lambda <== 340 nm to lower energy, so that the photochromic forward reaction can proceed with visible light excitation by utilization of the low-energy absorptions characteristic
07/13/2010US7754879 Porphyrin compound, albumin inclusion compound thereof and artificial oxygen carrier
07/13/2010US7754732 such as 4-Oxo-2-phenyl-1,3,8-triaza-spiro[4,5]dec-1-ene-8-carboxylic acid{1-7-methyl-1H-indazol-5-yl methyl)-2-[1,4]bipiperidinyl-1'-yl-2-oxo-ethyl}-amide, used as antagonists of calcitonin gene-related peptide receptors; used in the therapy of headaches and respiratory system disorders
07/13/2010US7754722 Piperazine derivatives and methods of use
07/13/2010US7754721 Arylpiperazine derivatives and uses thereof
07/13/2010US7754719 Substituted piperidine derivatives as somatostatin SST1 receptor antagonists
07/13/2010US7754716 vatalanib succinate (PTK787) and temozolomide; glioblastomas
07/13/2010US7754714 (1S, 2R)-N4-(2-Aminocarbonylcyclopent-1-yl)-5-fluoro-N2-[4-(4-methylpiperazin-1-yl)-3-methylphenyl]-2,4-pyrimidinediamine, having antiproliferative activity, used to inhibit cellular proliferation and to treat proliferate diseases such as cancers
07/13/2010US7754709 Tetracyclic thiophenepyrimidinone compounds as inhibitors of 17β hydroxysteroid dehydrogenase compounds
07/13/2010US7754189 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
07/13/2010US7754139 Method for preparing triethylenediamine (TEDA)
07/13/2010CA2608018C Anhydrous crystalline forms of n-[1-(2-ethoxyethyl)-5-(n-ethyl-n-methylamino)-7-(4-methylpyridin-2-yl-amino)-1h-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide
07/13/2010CA2567776C Vasopressin v1a antagonists
07/13/2010CA2449163C New use of 2-phenyl-substituted imidazotriazinones
07/13/2010CA2447623C Use of triazolopyrimidine derivatives as microbicides in material protection
07/13/2010CA2446820C Novel pyrrole derivatives as pharmaceutical agents
07/13/2010CA2352066C Process for the preparation of derivatized polymers
07/08/2010WO2010078430A1 Substituted 1h-pyrazolo[3,4-d]pyrimidine-6-amine compounds
07/08/2010WO2010078427A1 Substituted pyrazolo [3, 4-b] pyridine compounds
07/08/2010WO2010078408A1 Heteroaryl compounds useful as raf kinase inhibitors
07/08/2010WO2010077852A2 Method of inducing cleavage of amyloid precursor protein to form a novel fragment
07/08/2010WO2010077686A1 Isoindolinone and related analogs as sirtuin modulators
07/08/2010WO2010077680A2 Compositions of protein receptor tyrosine kinase inhibitors
07/08/2010WO2010077663A2 Substituted tetracyclic 1h-indeno (1,2-b) pyridine-2 (5h)-one analogs thereof and uses thereof
07/08/2010WO2010077613A1 Modulators of toll-like receptors
07/08/2010WO2010077589A2 Stat3 inhibitors and therapeutic methods using the same
07/08/2010WO2010042684A4 Pyrrolotriazine kinase inhibitors
07/08/2010WO2009143039A3 Heterocyclic compounds as factor ixa inhibitors
07/08/2010US20100174066 Process for preparing crystalline form i of olanzapine
07/08/2010US20100173945 Compounds with nootropic action, their preparation, pharmaceutical compositions containing them, and use thereof
07/08/2010US20100173932 Sub-type selective amides of diazabicycloalkanes
07/08/2010US20100173917 Urea derivatives as abl modulators
07/08/2010US20100173915 Pharmaceutical compositions for the treatment of chronic heart failure comprising pyrazolopyrimidinone derivative compound
07/08/2010US20100173914 Pharmaceuticals, compositions and methods of making and using the same
07/08/2010US20100173913 Pyrido-and pyrimidopyrimidine derivatives as anti-proliferative agents
07/08/2010US20100173897 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
07/08/2010US20100173895 Imidazolopyrimidines and imidazolotriazine derivatives as inhibitors of poly(adp-ribose)polymerase(parp)
07/08/2010US20100173892 Enantioselective synthesis of 6-amino-7-hydroxy-4,5,6,7-tetrahydro-imidazo[4,5,1-JK][1]-benzazepin-2[1H]-one and zilpaterol
07/08/2010US20100173891 Heterocyclic compounds, methods for the preparation thereof, and uses thereof
07/08/2010US20100173878 Organic compounds
07/08/2010US20100173824 Azepinoindole Derivatives As Pharmaceutical Agents
07/08/2010US20100172867 Substituted 1h-pyrazolo[3,4-d]pyrimidine-6-amine compounds
07/08/2010CA2748276A1 Substituted pyrazolo [3, 4-b] pyridine compounds
07/08/2010CA2748274A1 Heteroaryl compounds useful as raf kinase inhibitors
07/08/2010CA2748174A1 Substituted 1h-pyrazolo[3,4-d]pyrimidine-6-amine compounds
07/08/2010CA2746221A1 Isoindolinone and related analogs as sirtuin modulators
07/08/2010CA2746220A1 Compositions of protein receptor tyrosine kinase inhibitors
07/08/2010CA2745295A1 Modulators of toll-like receptors
07/07/2010EP2204368A1 4-sulfonylpiperidine derivatives
07/07/2010EP2203453A1 Pyrazolo[5, 1-c] [1,2,4]triazines, methods for preparation and use thereof
07/07/2010EP2203452A1 Pyrrolopyrimidine compounds
07/07/2010EP2203449A1 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
07/07/2010EP2203060A1 Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
07/07/2010EP1725561B1 5,6-dialkyl-7-amino-triazolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds
07/07/2010EP1725560B1 5,6-dialkyl-7-amino-triazolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds
07/07/2010EP1611133B1 Condensed n-heterocyclic compound and use thereoff as crf receptor antagonist
07/07/2010CN101772502A (7H-pyrr0l0 [2, 3-d] pyrimidin-4-yl) -piperazines as kinase inhibitors for the treatment of cancer and inflammation
07/07/2010CN101772501A Heterocyclic compounds and use thereof as ERK inhibitors
07/07/2010CN101772500A Imidazopyrazines as protein kinase inhibitors
07/07/2010CN101772493A gamma secretase modulators
07/07/2010CN101772475A Process for the resolution of zopiclone and intermediate compounds
07/06/2010US7750556 Triazole derivatives and use thereof in organic light-emitting diodes (OLEDs)
07/06/2010US7750160 inhibit p38, MAP kinase interacting serine/threonine kinase 2 (MKNK2 kinase) and serine-threonine kinases (STKs); treating proliferative diseases including cancer, leukemias; e.g. N-(isoxazolyl)urea compounds and thiourea compounds
07/06/2010US7750154 Amide derivatives
07/06/2010US7750151 Inhibitors of Akt activity
07/06/2010US7750149 Seven-membered heterocyclic carbenes and their metal complexes
07/06/2010US7750034 Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
07/06/2010US7750017 Anticancer agents; hyperproliferative diseases; 4-(phenylamino)benzothieno[2,3-d]pyrimidines; inhibit the tyrosine kinase activities of EGFR (erbB1) and HER2
07/06/2010US7750014 Imidazo[1,2-C]pyrimidinylacetic acid derivatives
07/06/2010US7750009 7-benzyloxy-6-chloro-2-piperazin-1-yl-4-pyrrolidin-1-yl-pteridine, uitable for treating respiratory system or gastrointestinal disorders, inflammatory diseases of the joints, skin or eyes, diseases of the peripheral or central nervous system and cancers
07/06/2010US7750008 poly(ADP-ribose) polymerase (PARP) inhibitors such as 9-[(Hydrozinooxy)carbonyl]-2,7-dihydro-6-methoxy 3H-pyrido-[4,3,2-de]phthalazin-3-one, used for treating neuron tissue damage resulting from ischemia and reperfusion injury, depression, inflammatory bowel disorders, arthritis, gout, pain and sepsis
07/06/2010US7750007 Imidazo[1,2-beta]pyridazine and pyrazolo[1,5-alpha]pyrimidine derivatives and their use as protein kinase inhibitors
07/06/2010US7750005 Substituted hexahydropyrazino [1,2-A] pyrimidine-4,7-dione derivatives, process for their preparation and their use as medicaments
07/06/2010US7750000 Substituted imidazo[1,2b]pyridazines as kinase inhibitors, their preparation and use as medicaments
07/06/2010US7749991 photosensitizers used in the photodynamic therapy of microbial infections, tumors, pre-cancerous and proliferative pathologies and/or in the diagnosis, as well as for blood and blood derivatives sterilization
07/06/2010US7749404 Inks, colorants, pigmented plastics for coatings, non-impact-printing material, color filters, cosmetics, polymeric ink particles, toners, fluorescent tracers; high in the efficiency of electrical energy utilisation and high in luminance
07/06/2010CA2248242C Malononitrile-derivative anion salts, and their uses as ionic conducting materials
07/01/2010WO2010075514A1 Fluorescent conjugated polymers with a bodipy-based backbone and uses thereof
07/01/2010WO2010075512A1 Polymers with bodipy-based backbone for solar cells